公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
公司地址 300 Professional Drive, Gaithersburg, MD, USA, 20879
電話號碼 +1 240 631-3200
傳真號碼 +1 240 631-3203
公司網頁 https://www.emergentbiosolutions.com
員工數量 900
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Coleen Glessner Executive Vice President, Quality and Ethics and Compliance 美元 602.14K 21/03/2025
Ms. Jessica Perl Senior Vice President, General Counsel and Corporate Secretary -- 21/03/2025
Mr. Simon C. Lowry, M.D. Chief Medical Officer and Head of Research and Development -- 21/03/2025
Mr. William Hartzel Senior Vice President, Manufacturing and Bioservice -- 21/03/2025
Mr. Paul Williams Senior Vice President, Products Business 美元 469.56K 21/03/2025
Mr. Richard S. Lindahl Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer 美元 638.19K 27/02/2026
Mr. Joseph C. Papa, M.B.A.,R.Ph. Director, President and Chief Executive Officer 美元 800.00K 27/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Keith A. Katkin Independent Director 27/02/2026
Mr. Neal F. Fowler Independent Director 27/02/2026
Mr. Donald W. DeGolyer Independent Director 27/02/2026
Mr. John D. Fowler, Jr Independent Director 03/03/2026
Ms. Sujata Dayal Independent Director 27/02/2026
Dr. Kathryn C. Zoon, PhD Independent Director 27/02/2026
Mr. Marvin L. White Independent Director 27/02/2026
Dr. Zsolt Harsanyi,PhD Chairman of The Board 27/02/2026
Mr. Ronald B. Richard Independent Director 27/02/2026
Mr. Joseph C. Papa, M.B.A.,R.Ph. Director, President and Chief Executive Officer 27/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:47)
代號 名稱 佔比% 持有日期
AAEQAlpha Architect US Equity 2 ETF0.004%22/01/2026
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.003%26/02/2026
ACSVAmerican Century Small Cp Val Insgts ETF0.003%28/02/2026
AVSUAvantis Responsible US Equity ETF0.002%28/02/2026
TMFXMotley Fool Next ETF0.002%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.001%25/02/2026
GUGGuggenheim Active Allocation Fund0.001%30/11/2025
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
HDGProShares Hedge Replication0.0001%27/02/2026
DXUVDimensional US Vector Equity ETF0.00002%27/02/2026
AIEQAmplify AI Powered Equity ETF<0.000001%27/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
CALFPacer US Small Cap Cash Cows 100 ETF<0.000001%22/12/2025
DEEPAcquirers Small and Micro Deep Value ETF<0.000001%27/02/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
HAPSHarbor Human Capital Factor US Sm CapETF<0.000001%18/02/2026
LITLSimplify Piper Sandler USSm-CpPLUSIncETF<0.000001%07/01/2026
MFIGMotley Fool Innovative Growth Factor ETF<0.000001%02/01/2026
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
SUREAdvisorShares Insider Advantage ETF<0.000001%02/02/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.